Literature DB >> 3283096

Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins.

R Labia1, A Morand, K Tiwari, J S Pitton, D Sirot, J Sirot.   

Abstract

We determined the kinetic constants for two plasmid-mediated beta-lactamases with strong activity against third-generation cephalosporins: CTX-1 and SHV-2. The enzymes had many similar properties: their synthesis was constitutive and they were significantly active against penicillins as well as cephalosporins. The two enzymes thus differed considerably from the chromosomal cephalosporinases, but bore some resemblance to the commonly-encountered plasmid-coded penicillinases, such as TEM beta-lactamases. Moreover, like the TEM enzymes, the plasmid-mediated CTX-1 and SHV-2 enzymes were highly sensitive to the action of the inhibitors clavulanic acid and sulbactam. These inhibitors protected cefotaxime from hydrolysis by these enzymes. Both CTX-1 and SHV-2 lacked activity against the cephamycins, cefoxitin, latamoxef (moxalactam) and cefotetan. The CTX-1 and SHV-2 enzymes had a low activity against oxacillin and were not sensitive to chloride ions. Thus, they were not related to the OXA type beta-lactamases. For the third-generation cephalosporins the rates of hydrolysis were high and thus bore no relation with those observed for the other presently-known beta-lactamases, with perhaps the exceptions of those produced by K. oxytoca. Imipenem was very resistant to the action of these CTX-1 and SHV-2 beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283096     DOI: 10.1093/jac/21.3.301

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.

Authors:  C E Smith; B S Tillman; A W Howell; R N Longfield; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Susceptibility of new beta-lactams to the expanded-spectrum beta-lactamase CTX-1.

Authors:  D Sirot; C Chanal; R Labia; J Sirot
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

Review 3.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

4.  In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.

Authors:  R J Fass; W W Gregory; R F D'Amato; J M Matsen; D N Wright; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

5.  Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France.

Authors:  M J Soilleux; A M Morand; G J Arlet; M R Scavizzi; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

6.  A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.

Authors:  D Sirot; C Recule; E B Chaibi; L Bret; J Croize; C Chanal-Claris; R Labia; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 7.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 8.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

9.  Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.

Authors:  A Vuye; G Verschraegen; G Claeys
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 10.  Origin and impact of plasmid-mediated extended-spectrum beta-lactamases.

Authors:  A Philippon; G Arlet; P H Lagrange
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.